|
1
|
GBD 2016 Causes of Death Collaborators.
Global, regional, and national age-sex specific mortality for 264
causes of death, 1980-2016: A systematic analysis for the global
burden of disease study 2016. Lancet. 390:1151–1210.
2017.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Townsend N, Wilson L, Bhatnagar P,
Wickramasinghe K, Rayner M and Nichols M: Cardiovascular disease in
Europe: Epidemiological update 2016. Eur Heart J. 37:3232–3245.
2016.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Ramakrishnan S, Anand V and Roy S:
Vascular endothelial growth factor signaling in hypoxia and
inflammation. J Neuroimmune Pharmacol. 9:142–60. 2014.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Jaipersad AS, Lip GY, Silverman S and
Shantsila E: The role of monocytes in angiogenesis and
atherosclerosis. J Am Coll Cardiol. 63:1–11. 2014.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Sharifpanah F, Behr S, Wartenberg M and
Sauer H: Mechanical strain stimulates vasculogenesis and expression
of angiogenesis guidance molecules of embryonic stem cells through
elevation of intracellular calcium, reactive oxygen species and
nitric oxide generation. Biochim Biophys Acta. 1863:3096–3105.
2016.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Rafii S, Butler JM and Ding BS: Angiocrine
functions of organ-specific endothelial cells. Nature. 529:316–325.
2016.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Döring Y, Pawig L, Weber C and Noels H:
The CXCL12/CXCR4 chemokine ligand/receptor axis in cardiovascular
disease. Front Physiol. 5(212)2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Schober A and Zernecke A: Chemokines in
vascular remodeling. Thromb Haemost. 97:730–737. 2007.PubMed/NCBI
|
|
9
|
Jacobson O and Weiss ID: CXCR4 chemokine
receptor overview: Biology, pathology and applications in imaging
and therapy. Theranostics. 3:1–2. 2013.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Yamaguchi J, Kusano KF, Masuo O, Kawamoto
A, Silver M, Murasawa S, Bosch-Marce M, Masuda H, Losordo DW, Isner
JM and Asahara T: Stromal cell-derived factor-1 effects on ex vivo
expanded endothelial progenitor cell recruitment for ischemic
neovascularization. Circulation. 107:1322–1328. 2003.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Segal MS, Shah R, Afzal A, Perrault CM,
Chang K, Schuler A, Beem E, Shaw LC, Li Calzi S, Harrison JK, et
al: Nitric oxide cytoskeletal-induced alterations reverse the
endothelial progenitor cell migratory defect associated with
diabetes. Diabetes. 55:102–109. 2006.PubMed/NCBI
|
|
12
|
Navidshad B, Liang JB and Jahromi MF:
Correlation coefficients between different methods of expressing
bacterial quantification using real time PCR. Int J Mol Sci.
13:2119–2132. 2012.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Matsuzawa Y, Guddeti RR, Kwon TG, Lerman
LO and Lerman A: Treating coronary disease and the impact of
endothelial dysfunction. Prog Cardiovasc Dis. 57:431–442.
2015.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Dai Z, Li M, Wharton J, Zhu MM and Zhao
YY: Prolyl-4 hydroxylase 2 (PHD2) deficiency in endothelial cells
and hematopoietic cells induces obliterative vascular remodeling
and severe pulmonary arterial hypertension in mice and humans
through hypoxia-inducible factor-2α. Circulation. 133:2447–2458.
2016.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Cesari F, Sofi F, Molino Lova R, Vannetti
F, Pasquini G, Cecchi F, Marcucci R, Gori AM and Macchi C: Mugello
Study Working Group. Aging process, adherence to mediterranean diet
and nutritional status in a large cohort of nonagenarians: Effects
on endothelial progenitor cells. Nutr Metab Cardiovasc Dis.
28:84–90. 2018.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Dai X, Yan X, Zeng J, Chen J, Wang Y, Chen
J, Li Y, Barati MT, Wintergerst KA, Pan K, et al: Elevating CXCR7
improves angiogenic function of EPCs via Akt/GSK-3β/Fyn-mediated
Nrf2 activation in diabetic limb ischemia. Circ Res. 120:e7–e23.
2017.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Bianconi V, Sahebkar A, Kovanen P,
Bagaglia F, Ricciuti B, Calabrò P, Patti G and Pirro M: Endothelial
and cardiac progenitor cells for cardiovascular repair: A
controversial paradigm in cell therapy. Pharmacol Ther.
181:156–168. 2018.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Werner N, Kosiol S, Schiegl T, Ahlers P,
Walenta K, Link A, Böhm M and Nickenig G: Circulating endothelial
progenitor cells and cardiovascular outcomes. N Engl J Med.
353:999–1007. 2005.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Napoli C, Hayashi T, Cacciatore F,
Casamassimi A, Casini C, Al-Omran M and Ignarro LJ: Endothelial
progenitor cells as therapeutic agents in the microcirculation: An
update. Atherosclerosis. 215:9–22. 2011.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Wara AK, Manica A, Marchini JF, Sun X,
Icli B, Tesmenitsky Y, Croce K and Feinberg MW: Bone marrow-derived
Kruppel-like factor 10 controls reendothelialization in response to
arterial injury. Arterioscler Thromb Vasc Biol. 33:1552–1560.
2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Ruiz A, Ruiz L, Colón-Caraballo M,
Torres-Collazo BJ, Monteiro JB, Bayona M, Fazleabas AT and Flores
I: Pharmacological blockage of the CXCR4-CXCL12 axis in
endometriosis leads to contrasting effects in proliferation,
migration, and invasion. Biol Reprod. 98:4–14. 2018.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Bianchi ME and Mezzapelle R: The chemokine
receptor CXCR4 in cell proliferation and tissue regeneration. Front
Immunol. 11(2109)2020.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Zheng H, Dai T, Zhou B, Zhu J, Huang H,
Wang M and Fu G: SDF-1alpha/CXCR4 decreases endothelial progenitor
cells apoptosis under serum deprivation by PI3K/Akt/eNOS pathway.
Atherosclerosis. 201:36–42. 2008.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Manning BD and Toker A: AKT/PKB signaling:
Navigating the network. Cell. 169:381–405. 2017.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Walton KL, Holt L and Sartor RB:
Lipopolysaccharide activates innate immune responses in murine
intestinal myofibroblasts through multiple signaling pathways. Am J
Physiol Gastrointest Liver Physiol. 296:G601–G611. 2009.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Wang YQ, Zhang JR, Li SD, He YY, Yang YX,
Liu XL and Wan XP: Aberrant methylation of breast and ovarian
cancer susceptibility gene 1 in chemosensitive human ovarian cancer
cells does not involve the phosphatidylinositol 3'-kinase-Akt
pathway. Cancer Sci. 101:1618–1623. 2010.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Polivka J Jr and Janku F: Molecular
targets for cancer therapy in the PI3K/AKT/mTOR pathway. Pharmacol
Ther. 142:164–175. 2014.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Zhou W, Guo S, Liu M, Burow ME and Wang G:
Targeting CXCL12/CXCR4 axis in tumor immunotherapy. Curr Med Chem.
26:3026–3041. 2019.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Orimo A, Gupta PB, Sgroi DC,
Arenzana-Seisdedos F, Delaunay T, Naeem R, Carey VJ, Richardson AL
and Weinberg RA: Stromal fibroblasts present in invasive human
breast carcinomas promote tumor growth and angiogenesis through
elevated SDF-1/CXCL12 secretion. Cell. 121:335–348. 2005.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Cheng L, Huang Z, Zhou W, Wu Q, Donnola S,
Liu JK, Fang X, Sloan AE, Mao Y, Lathia JD, et al: Glioblastoma
stem cells generate vascular pericytes to support vessel function
and tumor growth. Cell. 153:139–152. 2013.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Du R, Lu KV, Petritsch C, Liu P, Ganss R,
Passegué E, Song H, Vandenberg S, Johnson RS, Werb Z and Bergers G:
HIF1alpha induces the recruitment of bone marrow-derived vascular
modulatory cells to regulate tumor angiogenesis and invasion.
Cancer Cell. 13:206–220. 2008.PubMed/NCBI View Article : Google Scholar
|
